多靶点粪便DNA检测在结直肠癌筛查临床实践中的应用
研究分析匹兹堡大学医学中心2017年1月1日至2021年12月31日间的多靶点粪便DNA(mt-sDNA)检测使用情况,共91,664份订单涉及73,704名患者。54.7%完成检测,其中18.6%阳性。完成率随年龄增长而升高,黑种人患者完成率和阳性率均较低。
要点
- 73,704名患者中仅54.7%(40,337/73,704)完成mt-sDNA检测,7,424份(18.6%)阳性。
- 完成率随年龄升高:<50-59岁48.2%,60-69岁56.3%,≥70岁55.6%(P<0.0001)。
- 黑种人患者完成率38.8%低于白种人54.1%和亚裔56.9%,阳性率也较低(OR 0.65)。
核心结论
- 仅54.7%的患者完成了mt-sDNA检测订单,年龄较大者更可能完成检测和检测阳性,黑种人患者完成检测和检测阳性的可能性均较低,需进一步探索mt-sDNA的使用情况。
研究设计与样本
- 回顾性分析匹兹堡大学医学中心2017年1月1日至2021年12月31日间的mt-sDNA订单,共91,664份订单涉及73,704名患者,采用多变量模型评估完成与结果同年龄、性别和种族的关联。
主要发现
- 73,704名患者中40,337名(54.7%)完成了mt-sDNA检测,7,424名(18.6%)检测阳性。
- 完成率随年龄升高:<50-59岁组48.2%(12,818例),60-69岁组56.3%(14,982例),≥70岁组55.6%(9,850例)(P<0.0001)。
- 男性完成率52.7%(15,297/29,025)与女性53.3%(22,353/41,901)无显著差异(P=0.09)。
- 白种人完成率54.1%(34,874/64,512)和亚裔56.9%(493/867)高于黑种人38.8%(1,699/4,376)(P<0.0001)。
- 重复mt-sDNA订单后完成率下降,≥3次订单后完成率≤32%。
关键数值与推荐
- 多变量模型中,年龄较大与检测阳性的可能性较高相关(OR 1.22,95%CI 1.20-1.24,P<0.0001)。
- 黑种人患者检测阳性的比值比较低(OR 0.65,95%CI 0.56-0.76,P<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步探索mt-sDNA的使用情况,包括更好地理解 uptake、适当性和结肠镜检查结局评估的决定因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Few studies have evaluated multitarget stool DNA (mt-sDNA) in clinical practice. We analyzed mt-sDNA utilization at the University of Pittsburgh Medical Center. METHODS: We assessed mt-sDNA orders between January 1, 2017, and December 31, 2021. Data collection included electronic capture of mt-sDNA orders, completed stool submissions, and test results. Multivariable models were used to assess associations between mt-sDNA completion and results and age, sex, and race. RESULTS: There were 91,664 mt-sDNA orders in 73,704 patients. A total of 54.7% (40,337/73,704) completed an mt-sDNA test, and 7,424 (18.6%) tested positive. Completion rates increased by age <50-59 years (N = 12,818; 48.2%), 60-69 years (14,982; 56.3%), and ≥70 years (N = 9,850; 55.6%) ( P < 0.0001). The completion rate for males (52.7%; 15,297/29,025) did not differ significantly from females (53.3%; 22,353/41,901) ( P = 0.09). By race, the completion rates of White patients (54.1%; 34,874/64,512) and Asian patients (56.9%; 493/867) were higher than those of Black patients (38.8%; 1,699/4,376) ( P < 0.0001). Test completion declined with repeat mt-sDNA orders, with ≤32% completion rate after ≥3 orders. In a multivariable model, older age was associated with greater likelihood of a positive test (odds ratio 1.22, 95% confidence interval 1.20-1.24, P < 0.0001), and Black patients had lower odds of a positive test (odds ratio 0.65, 95% confidence interval 0.56-0.76, P < 0.0001). DISCUSSION: Only 54.7% of patients completed their mt-sDNA test order. Older individuals were more likely to complete testing and test positive. Black patients were less likely to complete testing and, unexpectedly, less likely to test positive. Further exploration of mt-sDNA utilization including better understanding of the determinants of uptake, appropriateness, and evaluation of outcomes at colonoscopy is needed.
引用
- Jiang L, Yang K, Saul M, et al. Multitarget Stool DNA Testing for Colorectal Cancer Screening in Clinical Practice. Am J Gastroenterol. 2024. PMID: 39787355. doi:10.14309/ajg.0000000000003276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。